歐舒丹(00973.HK)逆漲13%創逾四個月高 全年多賺60%大增末期息
歐舒丹(00973.HK)全年業績強勁兼大增末期息,富瑞上調歐舒丹目標價10%至40.3元,以反映業績優於該行預期;裏昂績後維持歐舒丹「買入」評級,目標價微降至34.2元。該股今早逆市挑戰牛熊線(27.3元),最高見27.75元,創逾四個月高,現報27.1元,逆市急漲13%,成交增至118萬股。
歐舒丹昨天收市後公佈,截至3月止全年純利按年升60%至2.42億歐元(下同)創新高,每股盈利0.165元,末期股息按年增近79%至6.585歐分。期內,銷售淨額按年升近16%至17.81億元;經營溢利按年升逾43%至3.1億元創紀錄高;經營溢利率按年擴大3.3個百分點至17.4%,爲集團上市以來的最高水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.